Adult T-cell Leukemia/lymphoma - 89 Studies Found
| Completed |
: Lenalidomide in HTLV-1 Adult T-Cell Leukemia : Adult T Cell Leukemia/Lymphoma : 2011-01-10 : Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc |
| Completed |
: A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma :
|
| Active, not recruiting |
: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) : Adult T-cell Leukemia-Lymphoma : 2012-06-19 :
|
| Active, not recruiting |
: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia : Adult T-Cell Leukemia (ATL) : 2009-06-17 :
|
| Completed |
: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma : Adult T-cell Leukemia-lymphoma : 2009-06-09 : Biological: KW-0761 KW-0761 is administered weekly for 8 weeks as an intravenous infusion of 2 hours at |
| Active, not recruiting |
: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma : Adult T-Cell Leukemia-Lymphoma : 2012-11-07 : Drug: Lenalidomide 25 mg of Lenalidomide administered orally once daily |
| Active, not recruiting |
: Evaluation and Treatment of Tall Statured Girls : Constitutional Tall Stature : 2015-12-13 : Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
| Completed |
: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) : HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) : 2011-08-16 : Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
| Recruiting |
: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma :
: 2016-04-10 :
|
| Recruiting |
: Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL) : Adult T-Cell Lymphoma (ATL) : 2016-11-01 : Drug: HBI-8000 Oral, twice weekly |